GlucoTrack Stock (NASDAQ:GCTK)

Ownership Financials Chart

Previous Close

$0.60

52W Range

$0.37 - $112.50

50D Avg

$2.56

200D Avg

$13.05

Market Cap

$321.81K

Avg Vol (3M)

$1.94M

Beta

0.68

Div Yield

-

GCTK Company Profile

GlucoTrack, Inc. is a medical device company that focuses on the design, development, and commercialization of novel technologies for people with diabetes. The company is developing the GlucoTrack CBGM, a long-term implantable continuous blood glucose monitoring system for use by Type 1 diabetes patients and insulin-dependent Type 2 diabetes patients.

Industry

Medical - Devices

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

15

IPO Date

Apr 25, 2013

Website

GCTK Performance

GCTK Financial Summary

	Dec 25	Dec 24	Dec 23
Revenue	-	-	-
Operating Income	-	$-14.55M	$-7.10M
Net Income	-	$-22.60M	$-7.10M
EBITDA	-	$-21.98M	$-7.08M
Basic EPS	-	$60.76	$-38.30
Diluted EPS	-	$60.76	$-38.30

Fiscal year ends in Dec 25 | Currency in USD

Peer Comparison

Ticker	Company
INM	InMed Pharmaceuticals Inc.
RDHL	RedHill Biopharma Ltd.
HSCS	HeartSciences Inc.
NDRA	ENDRA Life Sciences Inc.
BBLG	Bone Biologics Corporation
AKAN	Akanda Corp.
BGMS	Bio Green Med Solution, Inc.
VERO	Venus Concept Inc.
NAOV	NanoVibronix, Inc.
DHAI	DIH Holding US, Inc.